Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Graham

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|February 8, 2006
Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experimentsGordon Graham, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|August 27, 2002
Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect dataGordon Graham, Suneel Gupta, Leon Aarons
Journal of Biopharmaceutical Statistics|April 6, 2006
Sample size calculations based on generalized estimating equations for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons, Gordon Graham
Computer Methods and Programs in Biomedicine|May 19, 2005
A program for the optimum design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction modelsGordon Graham, Ivelina Gueorguieva, Kelly Dickens
Computer Methods and Programs in Biomedicine|September 6, 2005
The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experimentsKayode Ogungbenro, Gordon Graham, Ivelina Gueorguieva, et al.
Journal of Biopharmaceutical Statistics|March 11, 2008
Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic experimentsKayode Ogungbenro, Gordon Graham, Ivelina Gueorguieva, et al.
Statistics in Medicine|December 12, 2007
Bayesian sample size for exploratory clinical trials incorporating historical dataJohn Whitehead, Elsa Valdés-Márquez, Patrick Johnson, et al.
Journal of Biopharmaceutical Statistics|December 30, 2011
Evaluation of the pre-posterior distribution of optimized sampling times for the design of pharmacokinetic studiesStephen B Duffull, Gordon Graham, Kerrie Mengersen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2009
Combining MCMC with 'sequential' PKPD modellingDavid Lunn, Nicky Best, David Spiegelhalter, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 8, 2007
Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designsKayode Ogungbenro, Ivelina Gueorguieva, Oneeb Majid, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|February 8, 2006
Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experimentsGordon Graham, Leon Aarons
Journal of Pharmacokinetics and Pharmacodynamics|August 27, 2002
Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect dataGordon Graham, Suneel Gupta, Leon Aarons
Journal of Biopharmaceutical Statistics|April 6, 2006
Sample size calculations based on generalized estimating equations for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons, Gordon Graham
Computer Methods and Programs in Biomedicine|May 19, 2005
A program for the optimum design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction modelsGordon Graham, Ivelina Gueorguieva, Kelly Dickens
Computer Methods and Programs in Biomedicine|September 6, 2005
The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experimentsKayode Ogungbenro, Gordon Graham, Ivelina Gueorguieva, et al.
Journal of Biopharmaceutical Statistics|March 11, 2008
Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic experimentsKayode Ogungbenro, Gordon Graham, Ivelina Gueorguieva, et al.
Statistics in Medicine|December 12, 2007
Bayesian sample size for exploratory clinical trials incorporating historical dataJohn Whitehead, Elsa Valdés-Márquez, Patrick Johnson, et al.
Journal of Biopharmaceutical Statistics|December 30, 2011
Evaluation of the pre-posterior distribution of optimized sampling times for the design of pharmacokinetic studiesStephen B Duffull, Gordon Graham, Kerrie Mengersen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2009
Combining MCMC with 'sequential' PKPD modellingDavid Lunn, Nicky Best, David Spiegelhalter, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 8, 2007
Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designsKayode Ogungbenro, Ivelina Gueorguieva, Oneeb Majid, et al.
Pageof 3